Magnetic Resonance Imaging Investigation of Macrophages in Acute Cardiac Allograft Rejection After Heart Transplantation

Background—Current immunosuppressive therapy after heart transplantation either generally suppresses the recipient’s entire immune system or is mainly targeting T-lymphocytes. Monocytes/macrophages are recognized as a hallmark of acute allograft rejection, but the roles that they play are not well characterized in vivo, because the tools for accessing in situ macrophage infiltration are lacking. In this study, we used MRI to investigate the role of macrophages in acute heart allograft rejection by cellular and functional MRI with selectively depleted systemic macrophages without affecting other leukocyte population, as well as to explore the possibility that macrophages could be an alternative therapeutic target. Methods and Results—A rodent heterotopic working heart–lung transplantation model was used for studying acute allograft rejection. Systemic macrophages were selectively depleted by treating recipient animals with clodronate-liposomes. Macrophage infiltration in the graft hearts was monitored by cellular MRI with in vivo ultrasmall superparamagnetic iron oxide particles labeling. Graft heart function was evaluated by tagging MRI followed by strain analysis. Clodronate-liposome treatment depletes circulating monocytes/macrophages in transplant recipients, and both cellular MRI and pathological examinations indicate a significant reduction in macrophage accumulation in the rejecting allograft hearts. In clodronate-liposome–treated group, allograft hearts exhibited preserved tissue integrity, partially reversed functional deterioration, and prolonged graft survival, compared with untreated controls. Conclusions—Cardiac cellular and functional MRI is a powerful tool to explore the roles of targeted immune cells in vivo. Our results indicate that macrophages are essential in acute cardiac allograft rejection, and selective depletion of macrophages with clodronate-liposomes protects hearts against allograft rejection, suggesting a potential therapeutic avenue. Our findings show that there is a finite risk of forming an intraventricular mass, presumably from the cellular debris or lipid material. Further optimization of the dosing protocol is necessary before clinical applications.

[1]  M. Nahrendorf,et al.  Monocyte and Macrophage Heterogeneity in the Heart , 2013, Circulation research.

[2]  O. Korsgren,et al.  Pig islet xenograft rejection is markedly delayed in macrophage‐depleted mice: a study in streptozotocin diabetic animals , 2000, Xenotransplantation.

[3]  N. Van Rooijen,et al.  Subpopulations of Mouse Blood Monocytes Differ in Maturation Stage and Inflammatory Response1 , 2004, The Journal of Immunology.

[4]  O. J. Dunn Multiple Comparisons Using Rank Sums , 1964 .

[5]  Qing Ye,et al.  In situ labeling of immune cells with iron oxide particles: an approach to detect organ rejection by cellular MRI. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Y. Magata,et al.  Comparison of Contrast Agents for Atherosclerosis Imaging Using Cultured Macrophages: FDG Versus Ultrasmall Superparamagnetic Iron Oxide , 2013, The Journal of Nuclear Medicine.

[7]  L. Axel,et al.  Heart wall motion: improved method of spatial modulation of magnetization for MR imaging. , 1989, Radiology.

[8]  N. Van Rooijen,et al.  Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. , 1994, Journal of immunological methods.

[9]  Jerry L. Prince,et al.  Imaging heart motion using harmonic phase MRI , 2000, IEEE Transactions on Medical Imaging.

[10]  F. Weidemann,et al.  Monocytes/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  R. Atkins,et al.  Macrophages act as effectors of tissue damage in acute renal allograft rejection , 2003, Transplantation.

[12]  Tom MacGillivray,et al.  Ultrasmall Superparamagnetic Particles of Iron Oxide in Patients With Acute Myocardial Infarction: Early Clinical Experience , 2012, Circulation. Cardiovascular imaging.

[13]  C. A. Shaw,et al.  In Vivo Mononuclear Cell Tracking Using Superparamagnetic Particles of Iron Oxide: Feasibility and Safety in Humans , 2012, Circulation. Cardiovascular imaging.

[14]  P. Libby,et al.  Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis , 2012, The Journal of experimental medicine.

[15]  Silviu Itescu,et al.  Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[16]  J. Edwards,et al.  Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.

[17]  Qing Ye,et al.  Noninvasive evaluation of cardiac allograft rejection by cellular and functional cardiac magnetic resonance. , 2009, JACC. Cardiovascular imaging.

[18]  N. Otsu A threshold selection method from gray level histograms , 1979 .

[19]  D. Mosser,et al.  Regulatory macrophages: Setting the Threshold for Therapy , 2011, European journal of immunology.

[20]  R. Mannon Macrophages: contributors to allograft dysfunction, repair, or innocent bystanders? , 2012, Current opinion in organ transplantation.

[21]  N. Van Rooijen,et al.  Delayed graft rejection in pre-vascularised corneas after subconjunctival injection of clodronate liposomes , 2000 .

[22]  Ahmed Tawakol,et al.  PET/MRI of inflammation in myocardial infarction. , 2012, Journal of the American College of Cardiology.

[23]  L. Harrison,et al.  Evidence that macrophages are required for T-cell infiltration and rejection of fetal pig pancreas xenografts in nonobese diabetic mice. , 1998, Transplantation.

[24]  Ernst J. Rummeny,et al.  Different Capacity of Monocyte Subsets to Phagocytose Iron-Oxide Nanoparticles , 2011, PloS one.

[25]  N. Van Rooijen,et al.  Changes in cytokine mRNA levels in experimental corneal allografts after local clodronate-liposome treatment. , 1999, Investigative ophthalmology & visual science.

[26]  N. Ohkohchi,et al.  Effect of elimination of donor Kupffer cells and/or recipient macrophages on acute rejection in liver transplantation. , 2003, Hepato-gastroenterology.

[27]  Donald S. Williams,et al.  Detection of single mammalian cells by high-resolution magnetic resonance imaging. , 1999, Biophysical journal.

[28]  L. Axel,et al.  MR imaging of motion with spatial modulation of magnetization. , 1989, Radiology.

[29]  T. K. van den Berg,et al.  Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine. , 1996, Journal of immunological methods.

[30]  James I. Cohen,et al.  Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. , 2002, AJNR. American journal of neuroradiology.

[31]  W. Baldwin,et al.  Update on cardiac transplantation pathology. , 2007, Archives of pathology & laboratory medicine.

[32]  Michael Jerosch-Herold,et al.  Quantitative assessment of regional myocardial function with MR-tagging in a multi-center study: interobserver and intraobserver agreement of fast strain analysis with Harmonic Phase (HARP) MRI. , 2005, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.